EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availability EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving ...

WASHINGTON, D.C. (WRIC) — Virginians who take morphine to manage pain are asked to check their bottles after a voluntary recall. Bryant Ranch Prepack, Inc. is voluntarily recalling one lot of 30mg ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

Attention Deficit Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder leading to impairments in learning and behaviour. ADHD affects approx. 3-5% of adults and 5-9% of children and ...

An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2 proof-of-concept study suggest. In the trial, twice weekly ...

Auvelity (dextromethorphan/bupropion) is a prescription drug that’s used to treat depression. The drug comes as an extended-release tablet. It’s usually taken ...

Mordor Intelligence has published a new report on gabapentin market offering a comprehensive analysis of trends, growth drivers, and future projections.

EXXUA is now available through Aytu RxConnect pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving mor ...